By the end of this BC ECHO on Substance Use session, participants will be able to:
1) describe the treatment availability and current BC PharmaCare coverage process for buprenorphine extended-release (bup-ER) injection,
2) select bup-ER as a pharmacological intervention when appropriate, given clinical presentation, individual patient needs, circumstances, and preferences are met, and
3) safely and effectively administer bup-ER, including initiation, maintenance, and discontinuation when applicable